Method for treating multiple sclerosis

Details Method for treating multiple sclerosis Method for treating multiple sclerosis

1995-06-07

1997-10-21

Mullis, Jeffrey C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

558390, A01N 3302, A61K 31135

Patent

active

056797150

ABSTRACT:
The invention relates to a method of treating multiple sclerosis comprising administering an effective amount of (R)-(-)-N,2-dimethyl-N-2-propynylphenethylamine alone or in conjunction with an effective amount of interferon beta or an effective amount of amantadine.

REFERENCES:
patent: 5453428 (1995-09-01), Kaminski
patent: 5519061 (1996-05-01), Youdin et al.
Connelly, "Interferon Beta for Multiple Sclerosis", Annals of Pharmacotherapy, May 1994 28(5) 610-5 (Medline Abstract No. 94348160).
Desrouleaux et al. "Fatigue in Multiple Sclerosis: Pilot Trial of Selegiline", Neurology 41, 321 (Mar. 1991).
Physicians Desk Reference, 48.sup.th, ed, 1994, pp. 2309-2311.
L. Steinman, Autoimmune Disease, Scientific American 1993 Sep. 269 (3):106-114.

Affiliated with

Also associated with

Rating

Method for treating multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating multiple sclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1007235